Journal of Biomedical Nanotechnology · 2019 · 97 citations · 0 references
PharmacyOncologyPharmaceuticsChemotherapyDrug DeliveryNanoparticle Drug DeliveryCancer Drug DeliveryCancer NanomedicineLiposome-based DeliveryNanocarriers For TherapeuticsNanomedicineNanoparticle Delivery SystemsCancer NanotherapyChemotherapy DeliveryLiposomal Co-deliveryLiposomal Delivery SystemsLiposome Delivery SystemsMultifunctional NanoparticlesNanoparticle-based ChemotherapyTumor-targeted Drug Delivery
. The simultaneous delivery of PTX and siRNA synergistically increased the number of apoptotic cells and reduced angiogenesis. This delivery method exhibited significant advantages over combined delivery of PTX and siRNA separately by different liposomal drug delivery systems. Therefore, the simultaneous delivery of PTX and PLK1-targeted siRNA using AS1411 aptamer-functionalized liposome may have good potential clinical value for the therapy of breast cancer. Nanomedicine based on simultaneous delivery of chemotherapy drugs and siRNA gene provides an effective platform for improving tumor treatment methods.